跳转至内容
Merck
  • Systematic screening of different surface modifiers for the production of physically stable nanosuspensions.

Systematic screening of different surface modifiers for the production of physically stable nanosuspensions.

Journal of pharmaceutical sciences (2015-01-30)
Maria L A D Lestari, Rainer H Müller, Jan P Möschwitzer
摘要

The role of a surface modifier is important in the formation of stable nanosuspensions. In this study, a simple and systematic screening method for selecting optimum surface modifiers was performed by utilizing a low-energy wet ball milling method. Nine surface modifiers from different classes with different stabilization mechanisms were applied on six different models of active pharmaceutical ingredients (API). Particle size analysis showed that at concentration five times higher than the critical micelle concentration, SDS and sodium cholate (anionic surfactant) showed the highest percent success to produce stable nanosuspensions with particle size smaller than 250 nm. Similar findings were also shown by poloxamer 188 (nonionic surfactant) and hydroxypropylmethylcellulose E5 (polymeric stabilizer) at concentration 1% (w/v) and 0.8% (w/v), respectively. In addition, combinations of anionic surfactant and nonionic surfactant as well as combinations of anionic surfactant and polymeric stabilizer showed high percent success in the formation of stable nanosuspensions. In general, no correlation can be found between the physicochemical characteristics of the model API (molecular weight, melting point, log P, pKa, and crystallinity) with its feasibility to be nanosized. The concentration and the principle of stabilization of surface modifier determine the formation of stable nanosuspensions.

材料
货号
品牌
产品描述

Sigma-Aldrich
布洛芬, ≥98% (GC)
Sigma-Aldrich
N,N′-二琥珀酰亚胺碳酸酯, ≥95%
USP
布洛芬, United States Pharmacopeia (USP) Reference Standard
Supelco
布洛芬
Supelco
布洛芬, Pharmaceutical Secondary Standard; Certified Reference Material
布洛芬, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
N,N′-二琥珀酰亚胺碳酸酯, purum, ≥95.0% (NMR)
Sigma-Aldrich
布洛芬, meets USP testing specifications
布洛芬, European Pharmacopoeia (EP) Reference Standard